Author

Pingping Xu

Fudan University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

Bin YangiD· 1 shared Dingfeng WuiD· 1 shared Dongze Qiu· 1 shared Guoqing ZhangiD· 1 shared Lei LiuiD· 1 shared Liwen TaoiD· 1 shared Na JiaoiD· 1 shared Qian Long· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Bin YangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

An 8 Gene Bevacizumab Resistance Signature Predicts Prognosis and Reveals Immunosuppressive Microenvironment in Colorectal Cancer

Zhengchuan Niu, Dongze Qiu, Pingping Xu

The paper develops an 8-gene signature to predict bevacizumab resistance and prognosis in colorectal cancer, revealing an immunosuppressive microenvironment associated with poor outcomes.

bioRxiv · May 20, 2026 · PreprintBioinformatics

IBDkb: an AI-enhanced integrative knowledge base for inflammatory bowel disease research and drug discovery

Liwen Tao, SHIQING SHI, Ruixin Zhu, Z.H. Liu, Bin Yang, Lei Liu, Wanning Chen, Qian Long, Na Jiao, Guoqing Zhang, Pingping Xu, Dingfeng Wu

IBDkb integrates multi-source IBD data with AI tools to enhance research and drug discovery by enabling efficient exploration of drug-target-trial associations.

Database · Jan 1, 2026Peer-reviewedBioinformatics